Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro

OBJECTIVES: Conflicting data from studies on the potential role of multidrug resistance 1 gene polymorphisms in inflammatory bowel disease may result from the analysis of genetically and geographically distinct populations. Here, we investigated whether multidrug resistance 1 gene polymorphisms are associated with inflammatory bowel diseases in patients from Rio de Janeiro. METHODS: We analyzed 123 Crohn's disease patients and 83 ulcerative colitis patients to determine the presence of the multidrug resistance 1 gene polymorphisms C1236T, G2677T and C3435T. In particular, the genotype frequencies of Crohn's disease and ulcerative colitis patients were analyzed. Genotype-phenotype associations with major clinical characteristics were established, and estimated risks were calculated for the mutations. RESULTS: No significant difference was observed in the genotype frequencies of the multidrug resistance 1 G2677T/A and C3435T polymorphisms between Crohn's disease and ulcerative colitis patients. In contrast, the C1236T polymorphism was significantly more common in Crohn's disease than in ulcerative colitis (p = 0.047). A significant association was also found between the multidrug resistance 1 C3435T polymorphism and the stricturing form of Crohn's disease (OR: 4.13; p = 0.009), whereas no association was found with penetrating behavior (OR: 0.33; p = 0.094). In Crohn's disease, a positive association was also found between the C3435T polymorphism and corticosteroid resistance/refractoriness (OR: 4.14; p = 0.010). However, no significant association was found between multidrug resistance 1 gene polymorphisms and UC subphenotypic categories. CONCLUSION: The multidrug resistance 1 gene polymorphism C3435T is associated with the stricturing phenotype and an inappropriate response to therapy in Crohn's disease. This association with Crohn's disease may support additional pathogenic roles for the multidrug resistance 1 gene in regulating gut-microbiota interactions and in mediating fibrosis. Understanding the effects of several drugs associated with multidrug resistance 1 gene variants may aid in the selection of customized therapeutic regimens.

Saved in:
Bibliographic Details
Main Authors: Carvalho,Ana Teresa P., Fróes,Renata S.B., Esberard,Barbara C., Santos,Juliana C.V.C., Rapozo,Davy C. M., Grinman,Ana B., Simão,Tatiana A., Nicolau Neto,Pedro, Luiz,Ronir R., Carneiro,Antonio José V., Souza,Heitor S.P. de, Ribeiro-Pinto,Luis Felipe
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000500327
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322014000500327
record_format ojs
spelling oai:scielo:S1807-593220140005003272014-05-12Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de JaneiroCarvalho,Ana Teresa P.Fróes,Renata S.B.Esberard,Barbara C.Santos,Juliana C.V.C.Rapozo,Davy C. M.Grinman,Ana B.Simão,Tatiana A.Nicolau Neto,PedroLuiz,Ronir R.Carneiro,Antonio José V.Souza,Heitor S.P. deRibeiro-Pinto,Luis Felipe Multidrug Resistance 1 Gene Inflammatory Bowel Disease Crohn's Disease Brazilian Population Genotype-Phenotype Associations OBJECTIVES: Conflicting data from studies on the potential role of multidrug resistance 1 gene polymorphisms in inflammatory bowel disease may result from the analysis of genetically and geographically distinct populations. Here, we investigated whether multidrug resistance 1 gene polymorphisms are associated with inflammatory bowel diseases in patients from Rio de Janeiro. METHODS: We analyzed 123 Crohn's disease patients and 83 ulcerative colitis patients to determine the presence of the multidrug resistance 1 gene polymorphisms C1236T, G2677T and C3435T. In particular, the genotype frequencies of Crohn's disease and ulcerative colitis patients were analyzed. Genotype-phenotype associations with major clinical characteristics were established, and estimated risks were calculated for the mutations. RESULTS: No significant difference was observed in the genotype frequencies of the multidrug resistance 1 G2677T/A and C3435T polymorphisms between Crohn's disease and ulcerative colitis patients. In contrast, the C1236T polymorphism was significantly more common in Crohn's disease than in ulcerative colitis (p = 0.047). A significant association was also found between the multidrug resistance 1 C3435T polymorphism and the stricturing form of Crohn's disease (OR: 4.13; p = 0.009), whereas no association was found with penetrating behavior (OR: 0.33; p = 0.094). In Crohn's disease, a positive association was also found between the C3435T polymorphism and corticosteroid resistance/refractoriness (OR: 4.14; p = 0.010). However, no significant association was found between multidrug resistance 1 gene polymorphisms and UC subphenotypic categories. CONCLUSION: The multidrug resistance 1 gene polymorphism C3435T is associated with the stricturing phenotype and an inappropriate response to therapy in Crohn's disease. This association with Crohn's disease may support additional pathogenic roles for the multidrug resistance 1 gene in regulating gut-microbiota interactions and in mediating fibrosis. Understanding the effects of several drugs associated with multidrug resistance 1 gene variants may aid in the selection of customized therapeutic regimens. info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.69 n.5 20142014-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000500327en10.6061/clinics/2014(05)06
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Carvalho,Ana Teresa P.
Fróes,Renata S.B.
Esberard,Barbara C.
Santos,Juliana C.V.C.
Rapozo,Davy C. M.
Grinman,Ana B.
Simão,Tatiana A.
Nicolau Neto,Pedro
Luiz,Ronir R.
Carneiro,Antonio José V.
Souza,Heitor S.P. de
Ribeiro-Pinto,Luis Felipe
spellingShingle Carvalho,Ana Teresa P.
Fróes,Renata S.B.
Esberard,Barbara C.
Santos,Juliana C.V.C.
Rapozo,Davy C. M.
Grinman,Ana B.
Simão,Tatiana A.
Nicolau Neto,Pedro
Luiz,Ronir R.
Carneiro,Antonio José V.
Souza,Heitor S.P. de
Ribeiro-Pinto,Luis Felipe
Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro
author_facet Carvalho,Ana Teresa P.
Fróes,Renata S.B.
Esberard,Barbara C.
Santos,Juliana C.V.C.
Rapozo,Davy C. M.
Grinman,Ana B.
Simão,Tatiana A.
Nicolau Neto,Pedro
Luiz,Ronir R.
Carneiro,Antonio José V.
Souza,Heitor S.P. de
Ribeiro-Pinto,Luis Felipe
author_sort Carvalho,Ana Teresa P.
title Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro
title_short Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro
title_full Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro
title_fullStr Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro
title_full_unstemmed Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro
title_sort multidrug resistance 1 gene polymorphisms may determine crohn's disease behavior in patients from rio de janeiro
description OBJECTIVES: Conflicting data from studies on the potential role of multidrug resistance 1 gene polymorphisms in inflammatory bowel disease may result from the analysis of genetically and geographically distinct populations. Here, we investigated whether multidrug resistance 1 gene polymorphisms are associated with inflammatory bowel diseases in patients from Rio de Janeiro. METHODS: We analyzed 123 Crohn's disease patients and 83 ulcerative colitis patients to determine the presence of the multidrug resistance 1 gene polymorphisms C1236T, G2677T and C3435T. In particular, the genotype frequencies of Crohn's disease and ulcerative colitis patients were analyzed. Genotype-phenotype associations with major clinical characteristics were established, and estimated risks were calculated for the mutations. RESULTS: No significant difference was observed in the genotype frequencies of the multidrug resistance 1 G2677T/A and C3435T polymorphisms between Crohn's disease and ulcerative colitis patients. In contrast, the C1236T polymorphism was significantly more common in Crohn's disease than in ulcerative colitis (p = 0.047). A significant association was also found between the multidrug resistance 1 C3435T polymorphism and the stricturing form of Crohn's disease (OR: 4.13; p = 0.009), whereas no association was found with penetrating behavior (OR: 0.33; p = 0.094). In Crohn's disease, a positive association was also found between the C3435T polymorphism and corticosteroid resistance/refractoriness (OR: 4.14; p = 0.010). However, no significant association was found between multidrug resistance 1 gene polymorphisms and UC subphenotypic categories. CONCLUSION: The multidrug resistance 1 gene polymorphism C3435T is associated with the stricturing phenotype and an inappropriate response to therapy in Crohn's disease. This association with Crohn's disease may support additional pathogenic roles for the multidrug resistance 1 gene in regulating gut-microbiota interactions and in mediating fibrosis. Understanding the effects of several drugs associated with multidrug resistance 1 gene variants may aid in the selection of customized therapeutic regimens.
publisher Faculdade de Medicina / USP
publishDate 2014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000500327
work_keys_str_mv AT carvalhoanateresap multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT froesrenatasb multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT esberardbarbarac multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT santosjulianacvc multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT rapozodavycm multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT grinmananab multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT simaotatianaa multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT nicolaunetopedro multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT luizronirr multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT carneiroantoniojosev multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT souzaheitorspde multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
AT ribeiropintoluisfelipe multidrugresistance1genepolymorphismsmaydeterminecrohnsdiseasebehaviorinpatientsfromriodejaneiro
_version_ 1756432234293755904